Discriminative stimulus effects of nicotine in humans

Handbook of Experimental Pharmacology

Volumn 192, Issue , 2009, Pages 369-400

  Perkins, Kenneth A ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; MECAMYLAMINE; NICOTINE; NICOTINE GUM; NICOTINE PATCH; NOSE SPRAY; PLACEBO; TOBACCO SMOKE; TRIMETAPHAN; VARENICLINE; NICOTINIC AGENT;

ALCOHOL CONSUMPTION; CLINICAL TRIAL; DOSE RESPONSE; DRUG DEPENDENCE; DRUG DISCRIMINATION; DRUG EFFICACY; DRUG MEGADOSE; ENVIRONMENTAL FACTOR; GENETICS; HUMAN; MAXIMUM ALLOWABLE CONCENTRATION; NICOTINE REPLACEMENT THERAPY; NONHUMAN; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REST; REVIEW; SEX DIFFERENCE; SMOKING; SMOKING CESSATION; STIMULUS; TOBACCO DEPENDENCE; DISCRIMINATION LEARNING; DRUG EFFECT; FEMALE; INTRANASAL DRUG ADMINISTRATION; MALE; METABOLISM;

ADMINISTRATION, INTRANASAL; DISCRIMINATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; NICOTINE; NICOTINIC AGONISTS; SEX FACTORS; SMOKING;

EID: 63849276978     PISSN: 01712004     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-540-69248-5_13     Document Type: Review

References (103)

1. Abreu ME, Griffiths RR (1996) Drug tasting may confound human drug discrimination studies. Psychopharmacology 125:255-257
2. Audrain-McGovern J, Nigg J, Perkins KA (2009) Endophenotypes for nicotine dependence risk at or before initial nicotine exposure. In: Swan G (ed) Phenotypes and endophenotypes: foundations for genetic studies of nicotine use and dependence. NCI Monograph 22. National Cancer Institute, Rockville, MA
3. Barrett SP, Boileau I, Okker J, Pihl RO, Dagher A (2004) The hedonic response to cigarette smoking is proportional to dopamine release in the human striatum as measured by positron emission tomography and [11C] raclopride. Synapse 54:65-71
4. Benowitz NL, Henningfield JE (1994) Establishing a nicotine threshold for addiction. New Engl J Med 331:123-125
5. Benowitz NL, Jacob P, Fong I, Gupta S (1994) Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine. J Pharmacol Exper Ther 268:296-303
6. Benowitz NL, Zevin S, Jacob P III (1997) Sources of variability in nicotine and cotinine levels with use of nicotine nasal spray, transdermal nicotine, and cigarette smoking. Br J Clin Pharmacol 43:259-267
7. Bickel WK, Oliveto AH, Kamien JB, Higgins ST, Hughes JR (1993) A novel-response procedure enhances the selectivity and sensitivity of a triazolam discrimination in humans. J Pharmacol Exper Ther 264:360-367
8. Blendy JA, Strasser A, Walters CL, Perkins KA, Patterson F, Berkowitz R, Lerman C (2005) Reduced nicotine reward in obesity: cross comparison in human and mouse. Psychopharmacology 180:306-315
9. Byrd GD, Davis RA, Caldwell WS, Robinson JH, deBethizy JD (1998) A further study of FTC yield and nicotine absorption in smokers. Psychopharmacology 139:291-299
10. Chaudhri N, Caggiula AR, Donny EC, Palmatier MI, Liu X, Sved AF (2006) Complex interactions between nicotine and nonpharmacological stimuli reveal multiple roles for nicotine in reinforcement. Psychopharmacology 184:353-366
11. Cone EJ (1995) Pharmacokinetics and pharmacodynamics of cocaine. J Analy Toxicol 19:459-478
12. Desai RI, Terry P (2003) Evidence of cross-tolerance between behavioural effects of nicotine and cocaine in mice. Psychopharmacology 166:111-119
13. Desai RI, Barber DJ, Terry P (1999) Asymmetric generalization between the discriminative stimulus effects of nicotine and cocaine. Behav Pharmacol 10:647-656
14. deWit H (1991) Preference procedures for testing the abuse liability of drugs in humans. Br J Addict 86:1579-1586
15. Duka T, Tasker R, Russell K, Stephens DN (1998) Discriminative stimulus properties of nicotine at low doses: the effects of caffeine preload. Behav Pharmacol 9:219-229
16. Duka T, Seiss E, Tasker R (2002) The effects of extrinsic context on nicotine discrimination. Behav Pharmacol 13:39-47
17. Eissenberg T, Balster RL (2000) Initial tobacco use episodes in children and adolescents: current knowledge, future directions. Drug Alcohol Depend 59(Suppl 1):S41-S60
18. Fant RV, Schuh KJ, Stitzer ML (1995) Response to smoking as a function of prior smoking amounts. Psychopharmacology 119:385-390
19. Fischman MW, Foltin RW (1991) Utility of subjective-effects measurements in assessing abuse liability of drugs in humans. Br J Addict 86:1563-1570
20. Gasior M, Jaszyna M, Munzar P,Witkin JM, Goldberg SR (2002) Caffeine potentiates the discriminative stimulus effects of nicotine in rats. Psychopharmacology 162:385-395
21. Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB,Watsky EJ, Gong J,Williams KE, Reeves KR (2006) Varenicline, an a4b2 nicotinic acetylcholine receptor partial agonist, vs. sustained-release bupropion and placebo for smoking cessation. JAMA 296:47-55
22. Gourlay SG, Benowitz NL (1997) Arteriovenous differences in plasma concentration of nicotine and catecholamines and related cardiovascular effects after smoking, nicotine nasal spray, and intravenous nicotine. Clin Pharmacol Ther 62:453-463
23. Henningfield JE, Keenan R (1993) Nicotine delivery kinetics and abuse liability. J Consult Clin Psychol 61:743-750
24. Holtzman SG (1990) Discriminative stimulus effects of drugs: Relationship to potential for abuse. In: Modern methods in pharmacology, vol 6. Wiley, New York, pp 193-210
25. Jarbe TUC, Laaksonen T, Svensson R (1983) Influence of exteroceptive contextual conditions upon internal drug stimulus control. Psychopharmacology 80:31-34
26. Johanson CE (1991) Discriminative stimulus effects of psychomotor stimulants and benzodiazepines in humans. In: Glennon RA et al (eds) Drug discrimination: applications to drug abuse research. NIDA Research Monograph 116. U.S. Department of Health and Human Services, Washington, DC, pp 181-196
27. Jones HE, Garrett BE, Griffiths RR (1999) Subjective and physiological effects of intravenous nicotine and cocaine in cigarette smoking cocaine abusers. J Pharmacol Exp Ther 288:188-197
28. Kallman WM, Kallman MJ, Harry GJ, Woodson PP, Rosecrans JA (1982) Nicotine as a discriminative stimulus in human subjects. In: Colpaert FC, Slangen JL (eds) Drug discrimination: applications in CNS pharmacology. Elsevier Biomedical, Amsterdam, pp 211-218
29. Kalman D (2002) The subjective effects of nicotine: methodological issues, a review of experimental studies, and recommendations for future research. Nic Tob Res 4:25-70
30. Kalman D, Smith SS (2005) Does nicotine do what we think it does? A meta-analytic review of the subjective effects of nicotine in nasal spray and intravenous studies with smokers and nonsmokers. Nic Tob Res 7:317-333
31. Kamien JB, Bickel WK, Hughes JR, Higgins ST, Smith B (1993) Drug discrimination by humans compared to nonhumans: Current status and future directions. Psychopharmacology 111: 259-270
32. Kozlowski LT,Wilkinson DA, SkinnerW, Kent C, Franklin T, PopeMA(1989) Comparing tobacco cigarette dependence with other drug dependencies. JAMA 261:898-901
33. Lamb RJ, Preston KL, Schindler CW, Meisch RA, Davis F, Katz JL, Henningfield JE, Goldberg SR (1991) The reinforcing and subjective effects of morphine in post-addicts: a dose-response study. J Pharmacol Exp Ther 259:1165-1173
34. LeFoll B, Goldberg SR (2004) Rimonabant, a CB1 antagonist, blocks nicotine-conditioned place preferences. Neuroreport 15:2139-2143
35. LeFoll B, Goldberg SR (2005) Ethanol does not affect discriminative stimulus effects of nicotine in rats. Eur J Pharmacol 519:96-102
36. Lerman C, Perkins KA, Gould T (2009) Nicotine dependence endophenotypes in chronic smokers. In: Swan G (ed) Phenotypes, endophenotypes, and genetic studies of nicotine dependence. National Cancer Institute Monograph 22. U.S. Public Health Service, Washington DC
37. Madden PAF, Heath AC, Starmer GA, Whitfield JB, Martin NG (1995) Alcohol sensitivity and smoking history in men and women. Alcohol: Clin Exp Res 19:1111-1120
38. Malin DH, Alvarado CL, Woodhouse KS, Karp H, Urdiales E, Lay D, et al (2002) Passive immunization against nicotine attenuates nicotine discrimination. Life Sci 70:2793-2798
39. Mitchell SH, deWit H, Zacny JP (1995) Effects of varying ethanol dose on cigarette consumption in healthy normal volunteers. Behav Pharmacol 6:359-365
40. Mumford GK, Evans SM, Kaminski BJ, Preston KL, Sannerud CA, Silverman K, Griffiths RR (1994) Discriminative stimulus and subjective effects of theobromine and caffeine in humans. Psychopharmacology 115:1-8
41. Mitchell SH, deWit H, Zacny JP (1995) Effects of varying ethanol dose on cigarette consumption in healthy normal volunteers. Behav Pharmacol 6:359-365
42. Nemeth-Coslett R, Henningfield JE, O'Keefe MK, Griffiths RR (1986) Effects of mecamylamine on human cigarette smoking and subjective ratings. Psychopharmacology 88:420-425
43. Overton DA (1991) A historical perspective on drug discrimination. In: Glennon RA, Jarbe TUC, Frankenheim J (eds) Drug discrimination: applications to drug abuse research. NIDA Research Monograph 116. U.S. Department of Health and Human Services, Washington DC, pp 5-24
44. Patton GC, Coffey C, Carlin JB, Sawyer SM, Lynskey M (2005) Reverse gateways? Frequent cannabis use as a predictor or tobacco initiation and nicotine dependence. Addiction 100: 1518-1525
45. Perkins KA (1999a) Baseline-dependency of nicotine effects: a review. Behav Pharmacol 10: 597-615
46. Perkins KA (1999b) Nicotine discrimination in men and women. Pharmacol Biochem Behav 64:295-299
47. Perkins KA (2002) Chronic tolerance to nicotine in humans and its relationship to tobacco dependence. Nic Tob Res 4:405-422
48. Perkins KA (2008) Sex differences in nicotine reinforcement and reward: influences on the persistence of tobacco smoking. In: Bevins R, Caggiula AR (eds) The motivational impact of nicotine and its role in tobacco use. Springer, New York
49. Perkins KA, Scott JA (2008). Sex differences in long-term smoking cessation rates due to nicotine patch. Nic Tob Res 10(7):1245-1250
50. Perkins KA, Epstein LH, Stiller R, Jennings JR, Christiansen C, McCarthy T (1986) An aerosol spray alternative to cigarette smoking in the study of the behavioral and physiological effects of nicotine. Behav Res Meth Instr Comput 18:420-426
51. Perkins KA, DiMarco A, Grobe JE, Scierka A, Stiller RL (1994a) Nicotine discrimination in male and female smokers. Psychopharmacology 116:407-413
52. Perkins KA, Sexton JE, Reynolds WA, Grobe JE, Fonte C, Stiller RL (1994b) Comparison of acute subjective and heart rate effects of nicotine intake via tobacco smoking vs. nasal spray. Pharmacol Biochem Behav 47:295-299
53. Perkins KA, Sexton JE, Stiller RL, Fonte C, DiMarco A, Goettler J, Scierka A (1994c) Subjective and cardiovascular responses to nicotine combined with caffeine during rest and casual activity. Psychopharmacology 113:438-444
54. Perkins KA, Grobe JE, Mitchell SL, Goettler J, Caggiula AR, Stiller RL, Scierka A (1995) Acute tolerance to nicotine in smokers: lack of dissipation within two hours. Psychopharmacology 118:164-170
55. Perkins KA, D'Amico D, Sanders M, Grobe JE, Scierka A, Stiller RL (1996a) Influence of training dose on nicotine discrimination in humans. Psychopharmacology 126:132-139
56. Perkins KA, Grobe JE, Weiss D, Fonte C, Caggiula A (1996b) Nicotine preference in smokers as a function of smoking abstinence. Pharmacol Biochem Behav 55:257-263
57. Perkins KA, Sanders M, D'Amico D, Wilson A (1997) Nicotine discrimination and selfadministration as a function of smoking status. Psychopharmacology 131:361-370
58. Perkins KA, Donny E, Caggiula AR (1999a) Sex differences in nicotine effects and selfadministration: human and animal evidence. Nic Tob Res 1:301-305
59. Perkins KA, Fonte C, Sanders M, White W, Wilson AS (1999b) Effects of training dose and twoversus three-choice testing procedure on nicotine discrimination responding in humans. Psychopharmacology 145:418-425
60. Perkins KA, Sanders M, Fonte C, Wilson AS, White W, Stiller R, McNamara D (1999c) Effects of central and peripheral nicotinic blockade on human nicotine discrimination. Psychopharmacology 142:158-164
61. Perkins KA, Gerlach D, Broge M, Grobe JE, Wilson A (2000) Greater sensitivity to subjective effects of nicotine in nonsmokers high in sensation-seeking. Exp Clin Psychopharmacol 8: 462-471
62. Perkins KA, Fonte C, Ashcom J, Broge M, Wilson A (2001a) Subjective responses to nicotine in smokers may be associated with responses to caffeine and to alcohol. Exp Clin Psychopharmacol 9:91-100
63. Perkins KA, Fonte C, Meeker J, White W, Wilson A (2001b) The discriminative stimulus and reinforcing effects of nicotine in humans following nicotine pre-treatment. Behav Pharmacol 12:35-44
64. Perkins KA, Fonte C, Sanders M, Meeker J, Wilson A (2001c) Threshold doses for nicotine discrimination in smokers and nonsmokers. Psychopharmacology 155:163-170
65. Perkins KA, Gerlach D, Broge M, Fonte C, Wilson A (2001d) Reinforcing effects of nicotine as a function of smoking status. Exp Clin Psychopharmacol 9:243-250
66. Perkins KA, Gerlach D, Broge M, Grobe JE, Sanders M, Fonte C, Vender J, Cherry C, Wilson A (2001e) Dissociation of nicotine tolerance from tobacco dependence. J Pharmacol Exper Ther 296:849-856
67. Perkins KA, Gerlach D, Vender J, Grobe JE, Meeker J, Hutchison S (2001f) Sex differences in the subjective and reinforcing effects of visual and olfactory cigarette smoke stimuli. Nic Tob Res 3:141-150
68. Perkins KA, Broge M, Gerlach D, Sanders M, Grobe JE, Cherry C, Wilson AS (2002) Acute nicotine reinforcement, but not chronic tolerance, predicts withdrawal and relapse after quitting smoking. Health Psychol 2:332-339
69. Perkins KA, Sayette M, Conklin CA, Caggiula AR (2003) Placebo effects of tobacco smoking and other nicotine intake. Nic Tob Res 5:695-709
70. Perkins KA, Fonte C, Blakesley-Ball R, Stolinski A, Wilson AS (2005a) The influence of alcohol pre-treatment on the discriminative stimulus, subjective, and relative reinforcing effects of nicotine. Behav Pharmacol 16:521-529
71. Perkins KA, Fonte C, Blakesley-Ball R, Wilson AS (2005b) The discriminative stimulus, subjective, cardiovascular, and reinforcing effects of nicotine as a function of light physical activity. Nic Tob Res 7:591-600
72. Perkins KA, Fonte C, Stolinski A, Blakesley-Ball R, Wilson AS (2005c) The influence of caffeine on nicotine's discriminative stimulus, subjective, and reinforcing effects. Exper Clin Psychopharmacol 13:275-281
73. Perkins KA, Stitzer M, Lerman C (2006) Medication screening for smoking cessation: a proposal for new methodologies. Psychopharmacology 184:628-636
74. Perkins KA, Conklin CA, Levine MD (2007) Cognitive-behavioral therapy for smoking cessation. Routledge, New York Perkins KA, Ciccocioppo M, Conklin C, Milanak M, Grottenthaler A, Sayette M (2008). Mood influences on acute smoking responses are independent of nicotine intake and dose expectancy. J Abn Psychol 117(1):79-93
75. Picciotto MR, Caldarone BJ, King SL, Zachariou V (2000) Nicotinic receptors in the brain: links between molecular biology and behavior. Neuropsychopharmacology 22:451-465
76. Pomerleau CS, Pomerleau OF, Majchrzak MJ (1987) Mecamylamine pre-treatment increases subsequent nicotine self-administration as indicated by changes in plasma nicotine level. Psychopharmacology 91:391-393
77. Pomerleau OF, Pomerleau CS, Rose JE (1989) Controlled dosing of nicotine: a review of problems and progress. Ann Behav Med 11:158-163
78. Preston KL (1991) Drug discrimination methods in human drug abuse liability evaluations. Br J Addict 86:1587-1594
79. Preston KL, Bigelow GE (1991) Subjective and discriminative effects of drugs. Behav Pharmacol 2:293-313
80. Preston KL, Bigelow GE (1998) Opioid discrimination in humans: discriminative and subjective effects of progressively lower training dose. Behav Pharmacol 9:533-543
81. Ray R, Jepson C, Patterson F, Strasser AA, Rukstalis M, Perkins KA, Lynch K, O'Malley S, Berrettini W, Lerman C (2006) Association of OPRM1 Asn40Asp variant with the relative reinforcing value of nicotine in female smokers. Psychopharmacology 188:355-363
82. Roberts TA, Pennebaker JW (1995) Gender differences in perceiving internal states: toward a hisand-hers model of perceptual cues. Adv Exp Soc Psychol 27:143-175
83. Rose JE (1984) Discriminability of nicotine in tobacco smoke: implications for titration. Addict Behav 9:189-193
84. Rose JE (2006) Nicotine and non-nicotine factors in cigarette addiction. Psychopharmacology 184:274-285
85. Rose JE, CorrigallWA (1997) Nicotine self-administration in animals and humans: similarities and differences. Psychopharmacology 130:28-44
86. Rose JE, Sampson A, Levin ED, Henningfield JE (1989) Mecamylamine increases nicotine preference and attenuates nicotine discrimination. Pharmacol Biochem Behav 32:933-938
87. Rose JE,Westman E, Behm F (1996) Nicotine-mecamylamine combination treatment for smoking cessation. Drug Dev Res 38:243-256
88. Rose JE, Westman E, Behm F, Johnson MP, Goldberg JS (1999) Blockade of smoking satisfaction using the peripheral nicotinic antagonist trimethaphan. Pharmacol Biochem Behav 62:165-172
89. Rush CR, Critchfield TS, Troisi JR, Griffiths RR (1995) Discriminative stimulus effects of diazepam and buspirone in normal volunteers. J Exper Anal Behav 63:277-294
90. Rush CR, Higgins ST, Vansickel AR, Stoops WW, Lile JA, Glaser PEA (2005) Methylphenidate increases cigarette smoking. Psychopharmacology 181:781-789
91. Russell MAH (1979) Tobacco dependence: is nicotine rewarding or aversive? In: Krasnegor NA (ed) Cigarette smoking as a dependence process. NIDA Research Monograph 23, U.S. Department of Health and Human Services, Washington DC, pp 100-122
92. Schneider NG, Lunell E, Olmstead RE, Fagerstrom K-O (1996) Clinical pharmacokinetics of nasal nicotine delivery - A review and comparison to other nicotine systems. Clin Pharmacokinet 31:65-80
93. Shiffman S, Zettler-Segal M, Kassel J, Paty J, Benowitz NL, O'Brien G (1992) Nicotine elimination and tolerance in non-dependent cigarette smokers. Psychopharmacology 109:449-456
94. Singha AK, McCance-Katz EF, Heck SA, Kosten TR, Oliveto A (1999) Individual differences in humans responding under a cocaine discrimination procedure: discriminators versus nondiscriminators. Exper Clin Psychopharmacol 7:391-398
95. Smith BJ, BickelWK (1999) The novel-response procedure in humans. Pharmacol Biochem Behav 64:245-250
96. Stolerman IP (1999) Inter-species consistency in the behavioural pharmacology of nicotine dependence. Behav Pharmacol 10:559-580
97. Stolerman IP, Jarvis MJ (1995) The scientific case that nicotine is addictive. Psychopharmacology 117:2-10
98. Stolerman IP, Goldfarb T, Fink R, Jarvik ME (1973) Influencing cigarette smoking with nicotine antagonists. Psychopharmacology 28:217-259
99. Stolerman IP, Garcha HS, Pratt JA, Kumar R (1984) Role of training dose in discrimination of nicotine and related compounds by rats. Psychopharmacology 84:413-419
100. Stolerman IP, Samele C, Kamien JB, Mariathasan EA, Hague DS (1995) Bibliography of drug discrimination research, 1992-1994. Behav Pharmacol 6:643-668
101. U.S. Department of Health and Human Services (USDHHS) (1988) The health consequences of smoking: nicotine addiction. A report of the U S surgeon general. U.S. Public Health Service, Washington DC
102. van Hest A, Steckler T (1996) Effects of procedural parameters on response accuracy: lessons from delayed (non-) matching procedures in animals. Cog Brain Res 3:193-203
103. Young R, Glennon RA (2002) Nicotine and bupropion share a similar discriminative stimulus effect. Eur J Pharmacol 443:113-118